Medical Care

Global Model Species Market Research Report 2025

The global market for Model Species was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for Model Species is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Model Species is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Model Species in Drug Discovery is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Model Species include Shanghai Model Organisms Center, Inc., Gem Pharmatech Co., Ltd., Charles River Laboratories, Envigo, Taconic Biosciences, Jackson Laboratory, Shanghai SLAC, Joinn Laboratories, Crown Biosciences, Pharmalegacy, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Model Species, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Model Species.
The Model Species market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Model Species market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Model Species companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Shanghai Model Organisms Center, Inc.
Gem Pharmatech Co., Ltd.
Charles River Laboratories
Envigo
Taconic Biosciences
Jackson Laboratory
Shanghai SLAC
Joinn Laboratories
Crown Biosciences
Pharmalegacy
Syngene International
Janvier Labs
GenOway
Psychogenics
Horizon Discovery Group
Vitalstar Biotechnology
Segment by Type
Rat
Mouse
Zebrafish
Arabidopsis Thaliana
Others
Segment by Application
Drug Discovery
Basic Research
Toxicity Test
Parasitological Study
Hereditary Disease Study
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Model Species company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Model Species Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Rat
1.2.3 Mouse
1.2.4 Zebrafish
1.2.5 Arabidopsis Thaliana
1.2.6 Others
1.3 Market by Application
1.3.1 Global Model Species Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Drug Discovery
1.3.3 Basic Research
1.3.4 Toxicity Test
1.3.5 Parasitological Study
1.3.6 Hereditary Disease Study
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Model Species Market Perspective (2020-2031)
2.2 Global Model Species Growth Trends by Region
2.2.1 Global Model Species Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Model Species Historic Market Size by Region (2020-2025)
2.2.3 Model Species Forecasted Market Size by Region (2026-2031)
2.3 Model Species Market Dynamics
2.3.1 Model Species Industry Trends
2.3.2 Model Species Market Drivers
2.3.3 Model Species Market Challenges
2.3.4 Model Species Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Model Species Players by Revenue
3.1.1 Global Top Model Species Players by Revenue (2020-2025)
3.1.2 Global Model Species Revenue Market Share by Players (2020-2025)
3.2 Global Model Species Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Model Species Revenue
3.4 Global Model Species Market Concentration Ratio
3.4.1 Global Model Species Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Model Species Revenue in 2024
3.5 Global Key Players of Model Species Head office and Area Served
3.6 Global Key Players of Model Species, Product and Application
3.7 Global Key Players of Model Species, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Model Species Breakdown Data by Type
4.1 Global Model Species Historic Market Size by Type (2020-2025)
4.2 Global Model Species Forecasted Market Size by Type (2026-2031)
5 Model Species Breakdown Data by Application
5.1 Global Model Species Historic Market Size by Application (2020-2025)
5.2 Global Model Species Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Model Species Market Size (2020-2031)
6.2 North America Model Species Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Model Species Market Size by Country (2020-2025)
6.4 North America Model Species Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Model Species Market Size (2020-2031)
7.2 Europe Model Species Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Model Species Market Size by Country (2020-2025)
7.4 Europe Model Species Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Model Species Market Size (2020-2031)
8.2 Asia-Pacific Model Species Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Model Species Market Size by Region (2020-2025)
8.4 Asia-Pacific Model Species Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Model Species Market Size (2020-2031)
9.2 Latin America Model Species Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Model Species Market Size by Country (2020-2025)
9.4 Latin America Model Species Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Model Species Market Size (2020-2031)
10.2 Middle East & Africa Model Species Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Model Species Market Size by Country (2020-2025)
10.4 Middle East & Africa Model Species Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Shanghai Model Organisms Center, Inc.
11.1.1 Shanghai Model Organisms Center, Inc. Company Details
11.1.2 Shanghai Model Organisms Center, Inc. Business Overview
11.1.3 Shanghai Model Organisms Center, Inc. Model Species Introduction
11.1.4 Shanghai Model Organisms Center, Inc. Revenue in Model Species Business (2020-2025)
11.1.5 Shanghai Model Organisms Center, Inc. Recent Development
11.2 Gem Pharmatech Co., Ltd.
11.2.1 Gem Pharmatech Co., Ltd. Company Details
11.2.2 Gem Pharmatech Co., Ltd. Business Overview
11.2.3 Gem Pharmatech Co., Ltd. Model Species Introduction
11.2.4 Gem Pharmatech Co., Ltd. Revenue in Model Species Business (2020-2025)
11.2.5 Gem Pharmatech Co., Ltd. Recent Development
11.3 Charles River Laboratories
11.3.1 Charles River Laboratories Company Details
11.3.2 Charles River Laboratories Business Overview
11.3.3 Charles River Laboratories Model Species Introduction
11.3.4 Charles River Laboratories Revenue in Model Species Business (2020-2025)
11.3.5 Charles River Laboratories Recent Development
11.4 Envigo
11.4.1 Envigo Company Details
11.4.2 Envigo Business Overview
11.4.3 Envigo Model Species Introduction
11.4.4 Envigo Revenue in Model Species Business (2020-2025)
11.4.5 Envigo Recent Development
11.5 Taconic Biosciences
11.5.1 Taconic Biosciences Company Details
11.5.2 Taconic Biosciences Business Overview
11.5.3 Taconic Biosciences Model Species Introduction
11.5.4 Taconic Biosciences Revenue in Model Species Business (2020-2025)
11.5.5 Taconic Biosciences Recent Development
11.6 Jackson Laboratory
11.6.1 Jackson Laboratory Company Details
11.6.2 Jackson Laboratory Business Overview
11.6.3 Jackson Laboratory Model Species Introduction
11.6.4 Jackson Laboratory Revenue in Model Species Business (2020-2025)
11.6.5 Jackson Laboratory Recent Development
11.7 Shanghai SLAC
11.7.1 Shanghai SLAC Company Details
11.7.2 Shanghai SLAC Business Overview
11.7.3 Shanghai SLAC Model Species Introduction
11.7.4 Shanghai SLAC Revenue in Model Species Business (2020-2025)
11.7.5 Shanghai SLAC Recent Development
11.8 Joinn Laboratories
11.8.1 Joinn Laboratories Company Details
11.8.2 Joinn Laboratories Business Overview
11.8.3 Joinn Laboratories Model Species Introduction
11.8.4 Joinn Laboratories Revenue in Model Species Business (2020-2025)
11.8.5 Joinn Laboratories Recent Development
11.9 Crown Biosciences
11.9.1 Crown Biosciences Company Details
11.9.2 Crown Biosciences Business Overview
11.9.3 Crown Biosciences Model Species Introduction
11.9.4 Crown Biosciences Revenue in Model Species Business (2020-2025)
11.9.5 Crown Biosciences Recent Development
11.10 Pharmalegacy
11.10.1 Pharmalegacy Company Details
11.10.2 Pharmalegacy Business Overview
11.10.3 Pharmalegacy Model Species Introduction
11.10.4 Pharmalegacy Revenue in Model Species Business (2020-2025)
11.10.5 Pharmalegacy Recent Development
11.11 Syngene International
11.11.1 Syngene International Company Details
11.11.2 Syngene International Business Overview
11.11.3 Syngene International Model Species Introduction
11.11.4 Syngene International Revenue in Model Species Business (2020-2025)
11.11.5 Syngene International Recent Development
11.12 Janvier Labs
11.12.1 Janvier Labs Company Details
11.12.2 Janvier Labs Business Overview
11.12.3 Janvier Labs Model Species Introduction
11.12.4 Janvier Labs Revenue in Model Species Business (2020-2025)
11.12.5 Janvier Labs Recent Development
11.13 GenOway
11.13.1 GenOway Company Details
11.13.2 GenOway Business Overview
11.13.3 GenOway Model Species Introduction
11.13.4 GenOway Revenue in Model Species Business (2020-2025)
11.13.5 GenOway Recent Development
11.14 Psychogenics
11.14.1 Psychogenics Company Details
11.14.2 Psychogenics Business Overview
11.14.3 Psychogenics Model Species Introduction
11.14.4 Psychogenics Revenue in Model Species Business (2020-2025)
11.14.5 Psychogenics Recent Development
11.15 Horizon Discovery Group
11.15.1 Horizon Discovery Group Company Details
11.15.2 Horizon Discovery Group Business Overview
11.15.3 Horizon Discovery Group Model Species Introduction
11.15.4 Horizon Discovery Group Revenue in Model Species Business (2020-2025)
11.15.5 Horizon Discovery Group Recent Development
11.16 Vitalstar Biotechnology
11.16.1 Vitalstar Biotechnology Company Details
11.16.2 Vitalstar Biotechnology Business Overview
11.16.3 Vitalstar Biotechnology Model Species Introduction
11.16.4 Vitalstar Biotechnology Revenue in Model Species Business (2020-2025)
11.16.5 Vitalstar Biotechnology Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Model Species Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Rat
Table 3. Key Players of Mouse
Table 4. Key Players of Zebrafish
Table 5. Key Players of Arabidopsis Thaliana
Table 6. Key Players of Others
Table 7. Global Model Species Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Model Species Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Model Species Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Model Species Market Share by Region (2020-2025)
Table 11. Global Model Species Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Model Species Market Share by Region (2026-2031)
Table 13. Model Species Market Trends
Table 14. Model Species Market Drivers
Table 15. Model Species Market Challenges
Table 16. Model Species Market Restraints
Table 17. Global Model Species Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Model Species Market Share by Players (2020-2025)
Table 19. Global Top Model Species Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Model Species as of 2024)
Table 20. Ranking of Global Top Model Species Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Model Species Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Model Species, Headquarters and Area Served
Table 23. Global Key Players of Model Species, Product and Application
Table 24. Global Key Players of Model Species, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Model Species Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Model Species Revenue Market Share by Type (2020-2025)
Table 28. Global Model Species Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Model Species Revenue Market Share by Type (2026-2031)
Table 30. Global Model Species Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Model Species Revenue Market Share by Application (2020-2025)
Table 32. Global Model Species Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Model Species Revenue Market Share by Application (2026-2031)
Table 34. North America Model Species Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Model Species Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Model Species Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Model Species Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Model Species Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Model Species Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Model Species Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Model Species Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Model Species Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Model Species Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Model Species Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Model Species Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Model Species Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Model Species Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Model Species Market Size by Country (2026-2031) & (US$ Million)
Table 49. Shanghai Model Organisms Center, Inc. Company Details
Table 50. Shanghai Model Organisms Center, Inc. Business Overview
Table 51. Shanghai Model Organisms Center, Inc. Model Species Product
Table 52. Shanghai Model Organisms Center, Inc. Revenue in Model Species Business (2020-2025) & (US$ Million)
Table 53. Shanghai Model Organisms Center, Inc. Recent Development
Table 54. Gem Pharmatech Co., Ltd. Company Details
Table 55. Gem Pharmatech Co., Ltd. Business Overview
Table 56. Gem Pharmatech Co., Ltd. Model Species Product
Table 57. Gem Pharmatech Co., Ltd. Revenue in Model Species Business (2020-2025) & (US$ Million)
Table 58. Gem Pharmatech Co., Ltd. Recent Development
Table 59. Charles River Laboratories Company Details
Table 60. Charles River Laboratories Business Overview
Table 61. Charles River Laboratories Model Species Product
Table 62. Charles River Laboratories Revenue in Model Species Business (2020-2025) & (US$ Million)
Table 63. Charles River Laboratories Recent Development
Table 64. Envigo Company Details
Table 65. Envigo Business Overview
Table 66. Envigo Model Species Product
Table 67. Envigo Revenue in Model Species Business (2020-2025) & (US$ Million)
Table 68. Envigo Recent Development
Table 69. Taconic Biosciences Company Details
Table 70. Taconic Biosciences Business Overview
Table 71. Taconic Biosciences Model Species Product
Table 72. Taconic Biosciences Revenue in Model Species Business (2020-2025) & (US$ Million)
Table 73. Taconic Biosciences Recent Development
Table 74. Jackson Laboratory Company Details
Table 75. Jackson Laboratory Business Overview
Table 76. Jackson Laboratory Model Species Product
Table 77. Jackson Laboratory Revenue in Model Species Business (2020-2025) & (US$ Million)
Table 78. Jackson Laboratory Recent Development
Table 79. Shanghai SLAC Company Details
Table 80. Shanghai SLAC Business Overview
Table 81. Shanghai SLAC Model Species Product
Table 82. Shanghai SLAC Revenue in Model Species Business (2020-2025) & (US$ Million)
Table 83. Shanghai SLAC Recent Development
Table 84. Joinn Laboratories Company Details
Table 85. Joinn Laboratories Business Overview
Table 86. Joinn Laboratories Model Species Product
Table 87. Joinn Laboratories Revenue in Model Species Business (2020-2025) & (US$ Million)
Table 88. Joinn Laboratories Recent Development
Table 89. Crown Biosciences Company Details
Table 90. Crown Biosciences Business Overview
Table 91. Crown Biosciences Model Species Product
Table 92. Crown Biosciences Revenue in Model Species Business (2020-2025) & (US$ Million)
Table 93. Crown Biosciences Recent Development
Table 94. Pharmalegacy Company Details
Table 95. Pharmalegacy Business Overview
Table 96. Pharmalegacy Model Species Product
Table 97. Pharmalegacy Revenue in Model Species Business (2020-2025) & (US$ Million)
Table 98. Pharmalegacy Recent Development
Table 99. Syngene International Company Details
Table 100. Syngene International Business Overview
Table 101. Syngene International Model Species Product
Table 102. Syngene International Revenue in Model Species Business (2020-2025) & (US$ Million)
Table 103. Syngene International Recent Development
Table 104. Janvier Labs Company Details
Table 105. Janvier Labs Business Overview
Table 106. Janvier Labs Model Species Product
Table 107. Janvier Labs Revenue in Model Species Business (2020-2025) & (US$ Million)
Table 108. Janvier Labs Recent Development
Table 109. GenOway Company Details
Table 110. GenOway Business Overview
Table 111. GenOway Model Species Product
Table 112. GenOway Revenue in Model Species Business (2020-2025) & (US$ Million)
Table 113. GenOway Recent Development
Table 114. Psychogenics Company Details
Table 115. Psychogenics Business Overview
Table 116. Psychogenics Model Species Product
Table 117. Psychogenics Revenue in Model Species Business (2020-2025) & (US$ Million)
Table 118. Psychogenics Recent Development
Table 119. Horizon Discovery Group Company Details
Table 120. Horizon Discovery Group Business Overview
Table 121. Horizon Discovery Group Model Species Product
Table 122. Horizon Discovery Group Revenue in Model Species Business (2020-2025) & (US$ Million)
Table 123. Horizon Discovery Group Recent Development
Table 124. Vitalstar Biotechnology Company Details
Table 125. Vitalstar Biotechnology Business Overview
Table 126. Vitalstar Biotechnology Model Species Product
Table 127. Vitalstar Biotechnology Revenue in Model Species Business (2020-2025) & (US$ Million)
Table 128. Vitalstar Biotechnology Recent Development
Table 129. Research Programs/Design for This Report
Table 130. Key Data Information from Secondary Sources
Table 131. Key Data Information from Primary Sources
Table 132. Authors List of This Report


List of Figures
Figure 1. Model Species Picture
Figure 2. Global Model Species Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Model Species Market Share by Type: 2024 VS 2031
Figure 4. Rat Features
Figure 5. Mouse Features
Figure 6. Zebrafish Features
Figure 7. Arabidopsis Thaliana Features
Figure 8. Others Features
Figure 9. Global Model Species Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Model Species Market Share by Application: 2024 VS 2031
Figure 11. Drug Discovery Case Studies
Figure 12. Basic Research Case Studies
Figure 13. Toxicity Test Case Studies
Figure 14. Parasitological Study Case Studies
Figure 15. Hereditary Disease Study Case Studies
Figure 16. Model Species Report Years Considered
Figure 17. Global Model Species Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 18. Global Model Species Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 19. Global Model Species Market Share by Region: 2024 VS 2031
Figure 20. Global Model Species Market Share by Players in 2024
Figure 21. Global Top Model Species Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Model Species as of 2024)
Figure 22. The Top 10 and 5 Players Market Share by Model Species Revenue in 2024
Figure 23. North America Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. North America Model Species Market Share by Country (2020-2031)
Figure 25. United States Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Canada Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Europe Model Species Market Share by Country (2020-2031)
Figure 29. Germany Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. France Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. U.K. Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Italy Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Russia Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Nordic Countries Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Asia-Pacific Model Species Market Share by Region (2020-2031)
Figure 37. China Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Japan Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. South Korea Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Southeast Asia Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. India Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Australia Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Latin America Model Species Market Share by Country (2020-2031)
Figure 45. Mexico Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Brazil Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Middle East & Africa Model Species Market Share by Country (2020-2031)
Figure 49. Turkey Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Saudi Arabia Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. UAE Model Species Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 52. Shanghai Model Organisms Center, Inc. Revenue Growth Rate in Model Species Business (2020-2025)
Figure 53. Gem Pharmatech Co., Ltd. Revenue Growth Rate in Model Species Business (2020-2025)
Figure 54. Charles River Laboratories Revenue Growth Rate in Model Species Business (2020-2025)
Figure 55. Envigo Revenue Growth Rate in Model Species Business (2020-2025)
Figure 56. Taconic Biosciences Revenue Growth Rate in Model Species Business (2020-2025)
Figure 57. Jackson Laboratory Revenue Growth Rate in Model Species Business (2020-2025)
Figure 58. Shanghai SLAC Revenue Growth Rate in Model Species Business (2020-2025)
Figure 59. Joinn Laboratories Revenue Growth Rate in Model Species Business (2020-2025)
Figure 60. Crown Biosciences Revenue Growth Rate in Model Species Business (2020-2025)
Figure 61. Pharmalegacy Revenue Growth Rate in Model Species Business (2020-2025)
Figure 62. Syngene International Revenue Growth Rate in Model Species Business (2020-2025)
Figure 63. Janvier Labs Revenue Growth Rate in Model Species Business (2020-2025)
Figure 64. GenOway Revenue Growth Rate in Model Species Business (2020-2025)
Figure 65. Psychogenics Revenue Growth Rate in Model Species Business (2020-2025)
Figure 66. Horizon Discovery Group Revenue Growth Rate in Model Species Business (2020-2025)
Figure 67. Vitalstar Biotechnology Revenue Growth Rate in Model Species Business (2020-2025)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies